background image

Paid Clinical Trials Jersey City

Discover 1,562 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

for
Major Depressive Disorder
Location: 34 recruiting locations
Sponsor: Neumora Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06058013

Phase3, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: 26 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06863961

Phase2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis

for
Atopic Hand and Foot Dermatitis
Location: 25 recruiting locations
Sponsor: Eli Lilly and Company

Sex: All

Age: 12+

Code: NCT06921759

Phase3, Recruiting
Active & Responsive

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

for
Asthma
Location: 61 recruiting locations
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Sex: All

Age: 12+

Code: NCT06664619

Phase3, Recruiting
Active & Responsive

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

for
Recurrent Endometrial Carcinoma,
Location: 219 recruiting locations
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05554328

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: 40 recruiting locations
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06869785

Phase3, Recruiting
Active & Responsive

WATER IV Prostate Cancer

for
Localized Prostate Cancer
Location: 19 recruiting locations
Sponsor: PROCEPT BioRobotics

Sex: Male

Age: 45+

Code: NCT06651632

Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: 19 recruiting locations
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial

for
Intracranial Aneurysm
Location: 6 recruiting locations
Sponsor: Galaxy Therapeutics INC

Sex: All

Age: 22 - 70+

Code: NCT05831202

Phase3, Recruiting